Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Microbiol Resour Announc ; 10(40): e0074421, 2021 Oct 07.
Article in English | MEDLINE | ID: covidwho-1455678

ABSTRACT

Nearly complete genome sequences were obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern and two variants of interest from nasopharyngeal swab samples obtained during surveillance activities in urban communities, among individuals with no previous travel history, in Santo Domingo, Dominican Republic.

2.
Am J Trop Med Hyg ; 103(6): 2343-2346, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1389658

ABSTRACT

Seroprevalence surveys are of utmost importance to assess the proportion of a population that has developed antibodies against a newly introduced virus and could therefore potentially exhibit immunologic protection against subsequent infection. This study aims to understand the distribution of IgM and IgG antibodies in the Dominican Republic. We surveyed a total of 12,897 participants between April and June 2020 in 10 provinces of the Dominican Republic. Survey efforts in emerging hotspots yielded a positivity for all participants of anti-SARS-CoV-2 IgM of 3.8% and IgG of 5.4%, indicating that the pathogen was in circulation before the identification of those particular communities as hotspots. We found important age differences between participants who participated in the serological study where a higher mean age is associated IgM positivity and a lower age with IgG positivity. Our results highlight the need for strategies that involve community-based seroprevalence monitoring. These should preclude syndromic case identification. Also, the higher mean age of IgM-positive participants suggests that strategies based on syndromic surveillance could identify hotspots at later phases, based on the number of cases detected at the healthcare center, as such community-based seroprevalence monitoring may be an effective intervention for future outbreaks.


Subject(s)
Antibodies, Viral/blood , COVID-19/epidemiology , Immunoglobulin G/blood , Immunoglobulin M/blood , Pandemics , SARS-CoV-2/immunology , Adolescent , Adult , Age Factors , COVID-19/diagnosis , COVID-19/immunology , COVID-19/transmission , Child , Child, Preschool , Dominican Republic/epidemiology , Epidemiological Monitoring , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Seroepidemiologic Studies
SELECTION OF CITATIONS
SEARCH DETAIL